Our previous studies found that inhibiting the expression of TLR4 and NF-κB significantly alleviates cerebral ischemia injury [15, 27], and another recent study verified that suppression of the TLR4/NF-κB signaling pathway improved cerebral ischemia-reperfusion injury in rats [28]. This evidence concerns the gene NFKB1 and brain ischemia.